Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00254228 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction

A NA study, sponsored by Wicab.

Terminated
Registry status
NA
Development phase
60
Enrollment target

NCT00254228: Clinical Trial NA study, sponsored by Wicab.

NCT00254228 is a NA study that was terminated before completion, run by Wicab. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00254228, a NA study, was terminated before completion, sponsored by Wicab.

TERMINATED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the BrainPort™ balance device is safe and effective in the treatment of balance disorders in patients with Bilateral Vestibular Dysfunction.

Interventions

  • DEVICE Electrotactile sensory substitution

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2005-11
Est. Completion 2007-12
Phase NA
Wicab

4 total trials

Why NCT00254228 stopped before completion

NCT00254228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Electrotactile sensory substitution is the first listed.

NCT00254228 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00254228 about?

NCT00254228 is a clinical study titled "Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction". The purpose of this study is to determine whether the BrainPort™ balance device is safe and effective in the treatment of balance disorders in patients with Bilateral Vestibular Dysfunction.

What is the current status of trial NCT00254228?

This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2005-11. Estimated completion is 2007-12.

What interventions are being tested in trial NCT00254228?

The interventions under investigation include: Electrotactile sensory substitution (DEVICE).

Who is sponsoring clinical trial NCT00254228?

This trial is sponsored by Wicab, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00254228's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00254228, the US trial registry maintained by the National Library of Medicine. NCT00254228 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.